Clinical trial · Observational
Cardiovascular Assessment of Pediatric Cancer Survivors
Cardiovascular Assessment of Pediatric Cancer Survivors: Understanding Long-Term Effects and Risks
NCT05939089CI-TRIAL-00067920CASPERcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to evaluate cardiac and vascular health status of pediatric cancer survivors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Heart Failure | — | UNRESOLVED | — |
| Left Ventricular Dysfunction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ECG, Echocardiography, cTnI, NT-ProBNP | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Rate of LV Dysfunction
- timeFrame
- From the first visit at cardio-oncology division through study completion, an average of 2 years
- description
- Echocardiographic evaluation of left ventricular functions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed cancer at pediatric age Exclusion Criteria: * Having cancer after 18 years of age
References
Publications (0)
Data not yet available
No reference posted for this study.